← Leaderboards
John D Morrey
Utah State University
$14,814,199
Attributed
$14,814,199
Total exposure
10
Grants
9
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $4.1M · FY2005–16$5M$3.8M$2.5M$1.3M$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
Funding mix
By agency
NIH$14,814,199 · 10
By mechanism
N01$9,415,793 · 4
U54$3,086,906 · 2
R21$1,156,676 · 3
R33$1,154,824 · 1
Top collaborators
No co-investigators on record.
Others in their field
Top investigators on “Animal Model”
- David Heimbrook · Leidos Biomedical Research, Inc.$464,525,875
- Dennis R. Burton · Scripps Research Institute$204,129,233
- Joseph E Robertson · Oregon Health & Science University$126,125,279
- Peter Gordon Gillespie · Oregon Health And Science University$105,808,119
- David M Anderson · University Of Washington$102,920,737
- Polly Chang · Sri International$84,271,267
Research focus
Animal ModelVirusContractsCommunicable DiseasesWest Nile VirusBaseNeuronsEfficacy TestingAnimalsPathogenesisStandardizationPublishingVirus DiseasesCessation Of LifeViralResponseCell NucleusViral EncephalitisEncephalitisHamstersBlood - Brain Barrier AnatomyMouse ModelNervous System DisorderReceptor
Grant awards (40)
Targeting induction of calcium buffer proteins for treatment of viral encephaliti$436,424
R33 · FY2016 · AI · contact PI
Identifying deficits in brainstem respiratory circuits during viral encephalitis$212,400
R21 · FY2016 · NS · contact PI
Targeting induction of calcium buffer proteins for treatment of viral encephaliti$85,800
R33 · FY2016 · AI · contact PI
TASK A87: Mouse Model for Testing of Influenza Vaccine Candidates$17,552
N01 · FY2016 · AI · contact PI
Task A21: Small Animal Models for Biodefense Viruses$1,264,519
N01 · FY2015 · AI · contact PI
TASK A86: MOUSE MODELS FOR EVALUATION OF THERAPEUTICS AGAINST HUMAN SEASONAL INFLUENZA AND AVIAN INFLUENZA STRAINS WITH PANDEMIC POTENTIAL$420,000
N01 · FY2015 · AI · contact PI
Targeting induction of calcium buffer proteins for treatment of viral encephaliti$316,300
R33 · FY2015 · AI · contact PI
Cellular mechanisms of fatal respiratory insufficiency in arboviral encephalitis$208,260
R21 · FY2015 · NS · contact PI
Identifying deficits in brainstem respiratory circuits during viral encephalitis$177,000
R21 · FY2015 · NS · contact PI
TASK A87: Mouse Model for Testing of Influenza Vaccine Candidates$119,474
N01 · FY2015 · AI · contact PI
Task A57: MOUSE MODEL FOR EVALUATION OF MEDICAL COUNTERMEASURES FOR MERS$25,463
N01 · FY2015 · AI · contact PI
Task A66: Mouse Model of Low-pathogenicity Seasonal and Pandemic Influenza$1,796
N01 · FY2015 · AI · contact PI
Task A21: Small Animal Models for Biodefense Viruses$1,227,118
N01 · FY2014 · AI · contact PI
Task A15: Mouse Models for Evaluation of Influenza Vaccines and Adjuvants$570,271
N01 · FY2014 · AI · contact PI
Task A66: Mouse Model of Low-pathogenicity Seasonal and Pandemic Influenza$455,000
N01 · FY2014 · AI · contact PI
Task A19 HUMAN HEPATITIS B VIRUS (HBV) MOUSE MODELS FOR TESTING HBV THERAPEUTICS$384,609
N01 · FY2014 · AI · contact PI
Targeting induction of calcium buffer proteins for treatment of viral encephaliti$316,300
R33 · FY2014 · AI · contact PI
Cellular mechanisms of fatal respiratory insufficiency in arboviral encephalitis$173,550
R21 · FY2014 · NS · contact PI
Treatment of acute west nile virus diease and neurological sequelea$321,771
U54 · FY2013 · AI · contact PI
Targeting induction of calcium buffer proteins for treatment of viral encephaliti$192,733
R21 · FY2013 · AI · contact PI
Treatment of acute west nile virus diease and neurological sequelea$342,230
U54 · FY2012 · AI · contact PI
Targeting induction of calcium buffer proteins for treatment of viral encephaliti$192,733
R21 · FY2012 · AI · contact PI
Task A21: Small Animal Models for Biodefense Viruses$1,217,233
N01 · FY2011 · AI · contact PI
Pain Education$880,249
N01 · FY2011 · DA · contact PI
Task A37: Mouse Model for Influenza$854,000
N01 · FY2011 · AI · contact PI
A15: Mouse Models for Influenza Vaccines$519,578
N01 · FY2011 · AI · contact PI
Treatment of acute west nile virus diease and neurological sequelea$313,742
U54 · FY2011 · AI · contact PI
Task A30:Mouse Models for Orthopoxviruses$256,000
N01 · FY2011 · AI · contact PI
ANIMAL MODELS OF HUMAN VIRAL INFECTIONS FOR EVALUATION OF EXPERIMENTAL THERAPIE$105,584
N01 · FY2011 · AI · contact PI
Treatment of acute west nile virus diease and neurological sequelea$350,547
U54 · FY2010 · AI · contact PI
ANIMAL MODELS OF HUMAN VIRAL INFECTIONS FOR EVALUATION OF EXPERIMENTAL THERAPIE$181,459
N01 · FY2010 · AI · contact PI
ANIMAL MODELS OF HUMAN VIRAL INFECTIONS FOR EVALUATION OF EXPERIMENTAL THERAPIE$120,973
N01 · FY2010 · AI · contact PI
ANIMAL MODELS OF HUMAN VIRAL INFECTIONS FOR EVALUATION OF EXPERIMENTAL THERAPIE$354,491
N01 · FY2009 · AI · contact PI
Treatment of acute west nile virus diease and neurological sequelea$303,488
U54 · FY2009 · AI · contact PI
ANIMAL MODELS OF HUMAN VIRAL INFECTIONS FOR EVALUATION OF EXPERIMENTAL THERAPIE$240,424
N01 · FY2009 · AI · contact PI
Treatment and Disease Markers for Alpha and Flaviviruses$374,029
U54 · FY2008 · AI · contact PI
Treatment and Disease Markers for Alpha and Flaviviruses$437,104
U54 · FY2007 · AI · contact PI
Treatment and Disease Markers for Alpha and Flaviviruses$324,485
U54 · FY2006 · AI · contact PI
Treatment and Disease Markers for Alpha and Flaviviruses$319,510
U54 · FY2005 · AI
ANIMAL MODEL EVALUATIONS OF CANDIDATE HEPATITIS THERAPY$200,000
N01 · FY2000 · AI